GermanyStand No: 10A50
UBE offers custom chemical synthesis to the pharmaceutical industry and has introduced several intermediates using a variety of synthetic techniques to produce Catechol derivatives, 1, 3-Difunctional Chemicals, Heterocycles, Macrolides, Chiral Aminoacids and Quinolone carboxylic acid intermediates. Recently, UBE is gradually expanding its fine chemicals business and has state-of the-art cGMP multi-purpose plants: two API plants, two cGMP intermediate plants and three cGMP pilot plants in Japan. The site is regularly inspected by customers and by the FDA. UBE supplies a novel nucleophilic fluorinating agent “FLUOLEAD” and useful building blocks “Aromatic and heterocyclic SF5 compounds “ for pharmaceutical agents, pesticides, liquid crystals, conductive polymer, and higher performance organic materials.
GermanyStand No: 9H30
Umicore Precious Metals Chemistry strengths are a combination of customer orientation, process excellence, innovation leadership and diversity. Its customer focused technology platforms align worldwide all necessary resources from Research & Development to Marketing & Sales through Production, providing expertise in transition metals chemistry, high potency APIs, catalysts and high purity chemicals manufacturing, and related applications. It offers first class products and services allowing customers to use metal based technologies in the most effective and sustainable way. Umicore PMC's advanced chemicals and catalysts are mostly used in the industrial synthesis of active pharmaceutical ingredients, polymers, automotive catalytic converters or electronic materials. Products: Active Pharmaceutical Ingredients, Exclusive Synthesis of APIs, Homogeneous Catalysts, Pharmaceutical Intermediates
GreeceStand No: 9K40
Since its foundation, over 50 years ago, Uni-Pharma has grown from a small privately held company into a large and dynamic company, which currently holds the first position in unit sales among companies in the Greek pharmaceutical market. Uni-Pharma researches, develops, manufactures, markets and distributes pharmaceuticals, nutritional products and medical devices. Uni-Pharma's dynamic growth is based on investments in research and development, as well as on a working style, designed to develop sta skills and to encourage individual contribution and creativity. The production capacity exceeds 21 million pieces annually, making the UNI-PHARMA the first Greek company in unit sales in the Greek market.
IndiaStand No: 7F68NEP
Unilab is a quality manufacturer of APIs, Bulk Drugs, Finished Formulations, Speciality Chemicals and Personal Care Ingredients, since 1978. Committed to quality, our manufacturing plant is WHO GMP Certified and US FDA Approved, and we hold DMFs for all our products. We specialize in the manufacture of Antiseptics, Disinfectants, Antimicrobials, Biocides, Antifungals and Preservatives.
FranceStand No: 2G14
Union Plastic has specialised in designing and moulding plastic parts to the healthcare industry for 50 years. UP offers custom-made products (for pharmaceutical, veterinary, medical and diagnostic applications) and standard parts (dosing spoons and cups, dispensers, syringes). Certified ISO 13485 and 15378, manufacturing capability in ISO9 - ISO8 and ISO7 cleanrooms, with innovative IQ-OQ-PQ approach.
United StatesStand No: 14.1J10
Unipharma was established in Tamarac, Florida as the world's only purpose-built Blow-Fill-Seal and traditional filling manufacturing facility capable of offering the highest quality of liquid and semi-solid Rx, OTC and Nutraceutical formulations. Unipharma's 165,000 sq. ft. (16,500 sq. meters) make it one of the largest manufacturing companies in the Southeast United States. Unipharma operates under strict GMP guidelines and is FDA compliant. Our company specializes in Monodose filling including: BFS, FS and LIQUID StickPack, but also offer high speed conventional fill. Our Iso 5, 7 and 8 Certified Cleanrooms are made from the latest technologies available. Our fill volume sizes range from 0.25 - 500 mL in batches from 150 – 13,000 liters. Our product portfolio consists on products: sterile and non-sterile Rx, OTC and Nutraceutical with readily available dossiers for international registrations in the following therapeutic categories: · Analgesics · Anti-Acid · Anti-Diarrheal · Cold & Flu · Gastroenterology...
ThailandStand No: 14.0C20SSP
Since 1956, Unison Laboratories Co., Ltd, has grown from a domestic pharmaceutical company to one of the top five of the leading pharmaceutical manufacturers in Thailand. We produce around 200 pharmaceutical products (generic products) and almost 100 products in the pipeline/under registration. We export our products to more than 20 countries around the world and over 100 items have already been registered and sold in Asia-Pacific, Africa and Central America. In addition to PIC/s GMP and ISO 9001, we have received the following certifications: ISO 14001, ISO 50001 and OHSAS/TIS 18001 which will ensure that all our products manufactured including safety, environment and energy preservation are following the international standard of quality. Furthermore, we have also received Quality Award from Thai FDA 5 years consecutively in 2012, 2013, 2014, 2015 & 2016 and Green Industry Award from Ministry of Industry. We guarantee that all of our products completely pass through the strict Quality Control before going to the market.
FranceStand No: 3F52
Unither Pharmaceuticals, international CDMO, is the worldwide leader in Sterile Unit Doses (BFS) Manufacturing and offers pharmaceutical development and manufacturing services for various liquid and solid dosage forms. Unither produces: highly competitive niche drug products and medical devices; Sterile Unit-dose vials using Blow-Fill-Seal (BFS) technology; high-barrier, single-use liquid stick packs; and improved dry formulations, such as ready to use powder stick pack, succable and chewable tablets and effervescent tablets. We offer also capacity for bottle manufacturing. Unither Pharmaceuticals offers global or stand-alone services in: drug products; pharmaceutical development; formulation; analytical development and validation.
United KingdomStand No: 8H60
Univar distributes chemistry providing global connectivity for pharmaceutical producers. Our long-standing relationships with world leading producers gives access to a comprehensive portfolio of raw materials. These include excipients, colours, APIs, intermediates, solvents, white oils and process chemicals, delivered with the confidence that comes from Univar's supply chain accountability and reputation.
SpainStand No: 3G80
Unolab is a Spanish company specialized in contract manufacturing of unidose products. Using Bottlepack technology, Blow, Fill & Seal. Unolab manufactures all kind of products in several formats (from 0,2ml to 10 ml). From the purchase of raw materials to the shipping of final products.
United StatesStand No: 3H52
UPM Pharmaceuticals is a Bristol, Tennessee-based independent contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology industries. UPM provides high quality pharmaceutical drug development services that include formulation development, cGMP manufacturing and packaging, analytical method development and testing from concept through commercialization.
FinlandStand No: 2D42
UPM Raflatac is one of the world's leading producers of self-adhesive label materials. At CPhI we will showcase our latest innovation designed for medical device labelling and a range of labelling materials which support compliance with the FMD (2011/62/EU) regarding packaging for prescription drugs and high-risk, over-the-counter medicines.
SpainStand No: 9H40
The Uquifa group is a cGMP producer of Active Pharmaceutical Ingredients (APIs) and intermediates. The group operates 3 FDA inspected plants in Spain (2) and Mexico.With approximately 600,000 litres of reactor capacity, a complete range of chemical capabilities are available and include hydrogenation, chlorination, micronization and so forth. Highly qualified R&D teams and versatile pilot plants are available for product development, scale-up and commercialization, in addition to supplying API to the Generics Industry.Custom synthesis is conducted with the highest degree of confidentiality. Products -supplied to more than 500 companies in more than 60 countries globally- cover a wide range of therapeutic categories.
SpainStand No: 14.0F20
Uriach is a family-run pharmaceutical company that is dedicated to improving the health, wellbeing and quality of life of people all over the world. The company has two main business areas: Consumer Healthcare (OTC and Natural Care) and Business to Business (including NCEs, Generics and Contract Manufacturing). Present in Spain, Italy and Portugal, Uriach is currently in a period of international expansion with its products being sold in more than 70 countries. Founded in 1838, the company has always maintained a profitable, sustainable business model. Uriach currently employs 700 staff at two chemical and pharmaceutical production plants in the Barcelona area in which it produces its own products and also manufactures for third parties. Uriach's turnover in the 2016 financial year was 151 million euro, of which 60% sales were outside the domestic market.
GermanyStand No: 14.1C51
URSAPHARM is one of the leading companies in the field of ophthalmology in Germany. Our success is based on the wide range of pharmaceuticals and medicinal products which URSPAHARM provides for an effective and patient-oriented therapy. Adhering strictly to the most stringent national and international quality standards, URSAPHARM manufactures eye drops, eye ointments, nasal drops, nasal sprays and ear drops. Additionally, solid dosage forms such as tablets, film-coated tablets, sugar coated tablets, hard capsules and granulated powders of outstanding quality are manufactured on URSAPHARM`s modern production lines.
United StatesStand No: 9A62
IndiaStand No: 9J69
USV is a leading health care company with focus on Active Pharmaceutical Ingredients (marketed globally with emphasis on regulated markets of USA, European Union and Japan), Branded Generics and Bio-therapeutics. USV also specializes in Research and Development in Biotechnology, Drug Delivery and Chemistry. 26 APIs are currently on offer, others in various stages of development. Segments covered include Diabetes, Cardiology, CNS, Oncology, Dermatology and Ophthalmology. Competence in chemistry, expertise in polymorphism, capabilities in particle sizing, FDA approved manufacturing facilities and excellent Regulatory Support, are at the core of USV's aggressive API program.